FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079962655> ?p ?o ?g. }

• W2079962655 endingPage "791" @default.
• W2079962655 startingPage "786" @default.
• W2079962655 abstract "13-cis-Retinoic acid treatment causes insulin resistance and disturbances in lipid and glucose metabolism. We studied how 13-cis-retinoic acid affects inflammatory factors and adiponectin. A total of 23 healthy patients (age, 24.9 +/- 0.9 years; body mass index, 22.6 +/- 0.7 kg/m(2)) who received 13-cis-retinoic acid treatment of acne participated in the study. The patients were studied before the treatment, after 3 months of therapy, and 1 month after the treatment. Inflammatory parameters were measured, and a 4-hour oral glucose tolerance test was performed at each visit. Treatment with 13-cis-retinoic acid resulted in a significantly elevated serum adiponectin concentration (from 24.9 +/- 2.5 to 29.4 +/- 3.6 mg/L, P < .05), hemoglobin A(1c) (from 5.27% +/- 0.05% to 5.42% +/- 0.06%, P < .01), C-peptide area under the curve (from 314.2 +/- 16.6 to 350.0 +/- 21.0 (nmol . min)/L, P < .05), and triglycerides (from 0.97 +/- 0.06 to 1.29 +/- 0.10 mmol/L, P < .05), whereas high-density lipoprotein cholesterol decreased (from 1.50 +/- 0.07 to 1.38 +/- 0.08 mmol/L, P < .05). The increase in adiponectin during 13-cis-retinoic acid therapy correlated with baseline triglycerides (r = 0.51, P < .02). Many inflammatory markers, which were nonsignificantly elevated during therapy, decreased significantly after cessation of treatment. These were C-reactive protein (median from 1.78 to 1.23 mg/L, P < .05), soluble intercellular adhesion molecule 1 (from 210 +/- 10 to 204 +/- 10 microg/L, P < .02), ceruloplasmin (256 +/- 17 to 231 +/- 17 microg/L, P < .02), and erythrocyte sedimentation rate (from 6.4 +/- 1.3 to 4.7 +/- 0.9 mm/h, P < .02). Interleukin 6 concentration was unaffected by the therapy, but decreased significantly after the treatment (from 2.18 +/- 0.46 to 1.65 +/- 0.43 ng/L, P < .05). In conclusion, although treatment with 13-cis-retinoic acid results in disturbances in glucose and lipid metabolism, paradoxically serum adiponectin concentration increases. 13-cis-Retinoic acid has profound effects on the regulation of inflammatory markers." @default.
• W2079962655 created "2016-06-24" @default.
• W2079962655 creator A5001865794 @default.
• W2079962655 creator A5033908778 @default.
• W2079962655 creator A5048150526 @default.
• W2079962655 creator A5057319902 @default.
• W2079962655 creator A5075632567 @default.
• W2079962655 creator A5078061458 @default.
• W2079962655 date "2007-06-01" @default.
• W2079962655 modified "2023-10-16" @default.
• W2079962655 title "13-cis-Retinoic acid therapy induces insulin resistance, regulates inflammatory parameters, and paradoxically increases serum adiponectin concentration" @default.
• W2079962655 cites W1587875569 @default.
• W2079962655 cites W1971317805 @default.
• W2079962655 cites W1981261500 @default.
• W2079962655 cites W1987445229 @default.
• W2079962655 cites W1991100968 @default.
• W2079962655 cites W1994527422 @default.
• W2079962655 cites W2018135697 @default.
• W2079962655 cites W2020949125 @default.
• W2079962655 cites W2022991708 @default.
• W2079962655 cites W2051330839 @default.
• W2079962655 cites W2066397836 @default.
• W2079962655 cites W2066851739 @default.
• W2079962655 cites W2077574194 @default.
• W2079962655 cites W2083436346 @default.
• W2079962655 cites W2083818441 @default.
• W2079962655 cites W2091759162 @default.
• W2079962655 cites W2092136583 @default.
• W2079962655 cites W2108931588 @default.
• W2079962655 cites W2130451642 @default.
• W2079962655 cites W2130585857 @default.
• W2079962655 cites W2130789790 @default.
• W2079962655 cites W2137007782 @default.
• W2079962655 cites W2138750223 @default.
• W2079962655 cites W2154746915 @default.
• W2079962655 cites W2158989213 @default.
• W2079962655 cites W2166370133 @default.
• W2079962655 cites W2314710695 @default.
• W2079962655 cites W2316376271 @default.
• W2079962655 cites W2324841714 @default.
• W2079962655 cites W2334309509 @default.
• W2079962655 cites W2335984422 @default.
• W2079962655 doi "https://doi.org/10.1016/j.metabol.2007.02.002" @default.
• W2079962655 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17512311" @default.
• W2079962655 hasPublicationYear "2007" @default.
• W2079962655 type Work @default.
• W2079962655 sameAs 2079962655 @default.
• W2079962655 citedByCount "32" @default.
• W2079962655 countsByYear W20799626552012 @default.
• W2079962655 countsByYear W20799626552014 @default.
• W2079962655 countsByYear W20799626552015 @default.
• W2079962655 countsByYear W20799626552016 @default.
• W2079962655 countsByYear W20799626552017 @default.
• W2079962655 countsByYear W20799626552018 @default.
• W2079962655 countsByYear W20799626552019 @default.
• W2079962655 countsByYear W20799626552020 @default.
• W2079962655 countsByYear W20799626552021 @default.
• W2079962655 countsByYear W20799626552022 @default.
• W2079962655 crossrefType "journal-article" @default.
• W2079962655 hasAuthorship W2079962655A5001865794 @default.
• W2079962655 hasAuthorship W2079962655A5033908778 @default.
• W2079962655 hasAuthorship W2079962655A5048150526 @default.
• W2079962655 hasAuthorship W2079962655A5057319902 @default.
• W2079962655 hasAuthorship W2079962655A5075632567 @default.
• W2079962655 hasAuthorship W2079962655A5078061458 @default.
• W2079962655 hasConcept C104317684 @default.
• W2079962655 hasConcept C126322002 @default.
• W2079962655 hasConcept C134018914 @default.
• W2079962655 hasConcept C185592680 @default.
• W2079962655 hasConcept C2776782570 @default.
• W2079962655 hasConcept C2777391703 @default.
• W2079962655 hasConcept C2778917026 @default.
• W2079962655 hasConcept C2779306644 @default.
• W2079962655 hasConcept C2780221984 @default.
• W2079962655 hasConcept C2781121885 @default.
• W2079962655 hasConcept C55493867 @default.
• W2079962655 hasConcept C71924100 @default.
• W2079962655 hasConceptScore W2079962655C104317684 @default.
• W2079962655 hasConceptScore W2079962655C126322002 @default.
• W2079962655 hasConceptScore W2079962655C134018914 @default.
• W2079962655 hasConceptScore W2079962655C185592680 @default.
• W2079962655 hasConceptScore W2079962655C2776782570 @default.
• W2079962655 hasConceptScore W2079962655C2777391703 @default.
• W2079962655 hasConceptScore W2079962655C2778917026 @default.
• W2079962655 hasConceptScore W2079962655C2779306644 @default.
• W2079962655 hasConceptScore W2079962655C2780221984 @default.
• W2079962655 hasConceptScore W2079962655C2781121885 @default.
• W2079962655 hasConceptScore W2079962655C55493867 @default.
• W2079962655 hasConceptScore W2079962655C71924100 @default.
• W2079962655 hasIssue "6" @default.
• W2079962655 hasLocation W20799626551 @default.
• W2079962655 hasLocation W20799626552 @default.
• W2079962655 hasOpenAccess W2079962655 @default.
• W2079962655 hasPrimaryLocation W20799626551 @default.
• W2079962655 hasRelatedWork W159828373 @default.
• W2079962655 hasRelatedWork W1969072462 @default.
• W2079962655 hasRelatedWork W2066961600 @default.
• W2079962655 hasRelatedWork W207004869 @default.

• next